Samaritan's Collaborating Scientist to Become McGill's New Research Star
November 30, 2006 10:49 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 30, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Dr. Vassilios Papadopoulos, the lead scientist...
United States Patent Application Published for Samaritan's Novel Alzheimer's Drug SP-04
November 21, 2006 10:06 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 21, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today they received notice of the publication of its novel Alzheimer's...
Photo Release -- Samaritan Recognized for HIV Innovation
November 16, 2006 11:01 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 16, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan PharmaPlaz Ireland, Inc. (AMEX:LIV) a developer of innovative drugs, announced today it has been selected by the...
Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline
November 14, 2006 14:46 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 14, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Samaritan has reached a definitive agreement to...
Samaritan Receives AMEX Compliance Notice Letter
November 13, 2006 11:04 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 13, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) announced today, that on November 6, 2006, it received a notice from the American Stock Exchange, Inc. ("AMEX")...
Samaritan Submits IND to FDA for Novel Anti-Amyloidal Alzheimer's Drug Candidate Caprospinol
November 06, 2006 09:12 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan Pharma Ireland, Inc. (AMEX:LIV) developers of innovative drugs, announced today it has submitted an Investigational...
International Patent Application Published for Samaritan's Novel Alzheimer's Drug Caprospinol
November 03, 2006 10:27 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today we have received notice of the publication of its novel anti-amyloidal...
Photo Release -- Samaritan Completes Patient Enrollment in Proof of Concept PIIb Clinical Trial for HIV Entry Inhibitor Drug SP-01A
November 01, 2006 03:10 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 1, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has completed patient enrollment of its Phase IIb (Stage 2) 28 day...
Samaritan to Highlight Oral HIV Entry Inhibitor and Novel Alzheimer's Drug At BioPartnering Europe to Seek Partnering Opportunities
October 03, 2006 09:30 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will highlight the uniqueness and advantages of its oral HIV...
Taglich Brothers Issues Updated Research Report On Samaritan Pharmaceuticals
September 19, 2006 10:39 ET
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Sept. 19, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that Taglich Brothers published an updated Samaritan...